Remeron (mirtazapine): A novel antidepressant that disinhibits serotonin and norepinephrine by alpha 2 antagonism

被引：0
|
作者：
Stahl, SM
机构：
[1] UNIV CALIF SAN DIEGO,SCH MED,CLIN NEUROSCI RES CTR,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SCH MED,DEPT PSYCHIAT,LA JOLLA,CA 92093
来源：
PSYCHIATRIC ANNALS | 1997年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：14 / 16
页数：3
相关论文
共 50 条
  • [41] Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep–wake cycle architecture
    Amandine Descamps
    Colette Rousset
    Mark J. Millan
    Michael Spedding
    Philippe Delagrange
    Raymond Cespuglio
    Psychopharmacology, 2009, 205 (1) : 175 - 175
  • [42] INTERACTION OF A NOVEL ALPHA-2-ANTAGONIST AND MIANSERIN WITH DESIPRAMINE - EFFECTS OF BETA-ADRENERGIC RECEPTORS AND NOREPINEPHRINE TURNOVER
    QUINN, GP
    SWANSON, SK
    REID, MB
    FEDERATION PROCEEDINGS, 1982, 41 (04) : 1067 - 1067
  • [43] BIOCHEMICAL AND PHARMACOLOGICAL EVALUATION OF THE NOVEL ANTIDEPRESSANT AND SEROTONIN UPTAKE INHIBITOR 2-(3,4-DICHLOROBENZYL)-2-DIMETHYLAMINO-1-PROPANOL HYDROCHLORIDE
    GOURET, CJ
    PORSOLT, R
    WETTSTEIN, JG
    PUECH, A
    SOULARD, C
    PASCAUD, X
    JUNIEN, JL
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-1 (06): : 633 - 640
  • [44] PLATELET ACTIVATING FACTOR CAUSES CYCLIC FLOW VARIATIONS DESPITE THROMBOXANE SYNTHETASE INHIBITION AND PHARMACOLOGIC ANTAGONISM OF ALPHA-2-ADRENERGIC RECEPTORS AND SEROTONIN RECEPTORS
    APPRILL, P
    SCHMITZ, J
    CAMPBELL, W
    BUJA, LM
    ASHTON, J
    WILLERSON, J
    CIRCULATION, 1984, 70 (04) : 51 - 51
  • [45] A-80426, A POTENT AND SELECTIVE ALPHA(2)-ADRENOCEPTOR ANTAGONIST WITH SEROTONIN UPTAKE-BLOCKING ACTIVITY AND PUTATIVE ANTIDEPRESSANT-LIKE EFFECTS .2. PHARMACOLOGY PROFILE
    GIARDINA, WJ
    BUCKNER, SA
    BRUNE, ME
    HANCOCK, AA
    WISMER, CT
    MILICIC, I
    RATTIN, AJ
    ROUX, S
    WETTSTEIN, JG
    MEYER, MD
    PORSOLT, RD
    KERWIN, JF
    WILLIAMS, M
    DRUG DEVELOPMENT RESEARCH, 1995, 35 (04) : 246 - 260
  • [46] Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture
    Descamps, Amandine
    Rousset, Colette
    Millan, Mark
    Spedding, Michael
    Delagrange, Philippe
    Cespuglio, Raymond
    PSYCHOPHARMACOLOGY, 2009, 205 (01) : 93 - 106
  • [47] SELECTIVE AUGMENTATION OF ERGONOVINE (E) VASOCONSTRICTORY RESPONSE, BUT NOT SEROTONIN (HT), KCL, PROSTAGLANDIN-F2-ALPHA (PGF) AND NOREPINEPHRINE (NE), IN ATHEROSCLEROTIC QUAIL ARTERIES
    STANSELL, TK
    KU, DD
    SHIH, JCH
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 671 - 671
  • [48] A-80426, A POTENT ALPHA(2)-ADRENOCEPTOR ANTAGONIST WITH SEROTONIN UPTAKE BLOCKING ACTIVITY AND PUTATIVE ANTIDEPRESSANT-LIKE EFFECTS .1. BIOCHEMICAL PROFILE
    HANCOCK, AA
    BUCKNER, SA
    OHEIM, KW
    MORSE, PA
    BRUNE, ME
    MEYER, MD
    WILLIAMS, M
    KERWIN, JF
    DRUG DEVELOPMENT RESEARCH, 1995, 35 (04) : 237 - 245
  • [49] A Novel Translational Assay of Response Inhibition and Impulsivity: Effects of Prefrontal Cortex Lesions, Drugs Used in ADHD, and Serotonin 2C Receptor Antagonism
    Trevor Humby
    Jessica B Eddy
    Mark A Good
    Amy C Reichelt
    Lawrence S Wilkinson
    Neuropsychopharmacology, 2013, 38 : 2150 - 2159
  • [50] A Novel Translational Assay of Response Inhibition and Impulsivity: Effects of Prefrontal Cortex Lesions, Drugs Used in ADHD, and Serotonin 2C Receptor Antagonism
    Humby, Trevor
    Eddy, Jessica B.
    Good, Mark A.
    Reichelt, Amy C.
    Wilkinson, Lawrence S.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 (11) : 2150 - 2159
12345